Novo Nordisk A/S ADR buy BiotechBee
Start price
07.09.22
/
70%
€104.00
Target price
31.12.25
€180.00
Performance (%)
41.35%
End price
05.05.23
€147.00
Summary
This prediction ended on 05.05.23 with a price of €147.00. With a performance of 41.35% the BUY prediction by BiotechBee was a big success. A total of €1.10 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -1.167% | -1.167% | -33.681% | -60.923% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
According to BiotechBee what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 180,0